Use of Acetylamino benzoic acid compounds for nonsense suppression and the treatment of disease
US7763656B2 · kind B2 · utility
0Cited by
3References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 24, 2007 |
| Grant date | Jul 27, 2010 |
| Priority date | — |
| Expiry date | Apr 24, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel acetylamino benzoic acid compounds, methods of using and pharmaceutical compositions comprising an acetylamino benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.